Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Delft University of Technology (TU Delft)
- Eindhoven University of Technology (TU/e)
- University of Groningen
- Wageningen University & Research
- Maastricht University (UM)
- Amsterdam UMC
- University of Amsterdam (UvA)
- Utrecht University
- Leiden University
- Royal Netherlands Academy of Arts and Sciences (KNAW)
- AMOLF
- Centrum Wiskunde en Informatica (CWI)
- DIFFER
- Erasmus University Rotterdam
- Erasmus University Rotterdam (EUR)
- HFML-FELIX
- Radboud University
- Radboud University Medical Center (Radboudumc)
- University Medical Center Utrecht (UMC Utrecht)
- University of Twente (UT)
- Vrije Universiteit Amsterdam (VU)
- 11 more »
- « less
-
Field
-
that specifically and reversibly bind to the biomolecules of interest. In this PhD project, you will explore a novel direction: you will develop and test binder molecules for continuous sensing using de novo protein
-
, deadline 1 October! More information about the Full-time PhD in Business and Management programme can be found on the RSM website . Where to apply Website https://www.academictransfer.com/en/jobs/363549
-
mechanisms and developing disease models to preclinical therapy testing, clinical readiness and patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy
-
constrain it. Within an ongoing research project, we are developing a theory of an adaptive legal framework for the hydrogen economy. In this project, we aim to empirically test this theoretical framework in
-
bind to the biomolecules of interest. In this PhD project, you will explore a novel direction: you will develop and test binder molecules for continuous sensing using de novo protein design strategies
-
Particle Motion. The project includes nanoswitch design, sensor fabrication, sensor testing, and modelling. The longterm goal is to enable multiplexed continuous real-time sensing for applications in
-
mechanisms and model development to preclinical therapy testing, clinical readiness and patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology
-
. Establishing rigorous theoretical guarantees for convergence and scalability of the proposed learning algorithms. Extending the theory from analog circuits to more general dissipative networks. Testing and
-
)catalysts for synthetic applications. By seamlessly merging cutting-edge directed evolution, next-generation sequencing, and deep learning approaches, you will establish accelerated Design-Build-Test-Learn
-
different strain rates. You will investigate deformation mechanisms, strain localisation and damage from quasi-static to dynamic loading. A central challenge is developing optical testing methods that remain